NYSE:HAE is not too expensive for the growth it is showing.

Last update: Oct 31, 2024

HAEMONETICS CORP/MASS (NYSE:HAE) has caught the eye of our stock screener as an affordable growth stock. NYSE:HAE is displaying robust growth metrics and also excels in terms of profitability, solvency, and liquidity. Additionally, it appears to be reasonably priced. Let's delve into the details.

Analyzing Growth Metrics

Every stock receives a Growth Rating from ChartMill, ranging from 0 to 10. This rating assesses various growth aspects, including historical and projected EPS and revenue growth. NYSE:HAE boasts a 7 out of 10:

The Earnings Per Share has grown by an nice 12.86% over the past year.
HAE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.74% yearly.
Looking at the last year, HAE shows a quite strong growth in Revenue. The Revenue has grown by 9.47% in the last year.
Based on estimates for the next years, HAE will show a very strong growth in Earnings Per Share. The EPS will grow by 21.40% on average per year.
HAE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.74% yearly.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

Evaluating Valuation: NYSE:HAE

An integral part of ChartMill's stock analysis is the Valuation Rating, which spans from 0 to 10. This rating evaluates diverse valuation factors, including price to earnings and cash flows, while considering the stock's profitability and growth. NYSE:HAE has received a 6 out of 10:

Based on the Price/Earnings ratio, HAE is valued cheaply inside the industry as 86.63% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of HAE to the average of the S&P500 Index (30.51), we can say HAE is valued slightly cheaper.
93.58% of the companies in the same industry are more expensive than HAE, based on the Price/Forward Earnings ratio.
HAE is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.39, which is the current average of the S&P500 Index.
85.56% of the companies in the same industry are more expensive than HAE, based on the Enterprise Value to EBITDA ratio.
77.54% of the companies in the same industry are more expensive than HAE, based on the Price/Free Cash Flow ratio.
The excellent profitability rating of HAE may justify a higher PE ratio.
HAE's earnings are expected to grow with 16.85% in the coming years. This may justify a more expensive valuation.

Health Assessment of NYSE:HAE

To gauge a stock's financial health, ChartMill utilizes a Health Rating on a scale of 0 to 10. This comprehensive evaluation encompasses liquidity and solvency, both in absolute terms and in comparison to industry peers. NYSE:HAE has earned a 5 out of 10:

With a decent Altman-Z score value of 2.70, HAE is doing good in the industry, outperforming 63.10% of the companies in the same industry.
Looking at the Debt to FCF ratio, with a value of 17.79, HAE is in the better half of the industry, outperforming 71.12% of the companies in the same industry.
A Current Ratio of 3.76 indicates that HAE has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.76, HAE is in the better half of the industry, outperforming 60.96% of the companies in the same industry.
HAE has a Quick Ratio of 2.33. This indicates that HAE is financially healthy and has no problem in meeting its short term obligations.

Profitability Examination for NYSE:HAE

Discover ChartMill's exclusive Profitability Rating, a proprietary metric that assesses stocks on a scale of 0 to 10. It takes into consideration various profitability ratios and margins, both in absolute terms and relative to industry peers. Notably, NYSE:HAE has achieved a 8:

With an excellent Return On Assets value of 4.52%, HAE belongs to the best of the industry, outperforming 82.35% of the companies in the same industry.
With an excellent Return On Equity value of 12.69%, HAE belongs to the best of the industry, outperforming 88.77% of the companies in the same industry.
HAE's Return On Invested Capital of 7.17% is amongst the best of the industry. HAE outperforms 85.03% of its industry peers.
HAE's Profit Margin of 8.61% is amongst the best of the industry. HAE outperforms 81.28% of its industry peers.
In the last couple of years the Profit Margin of HAE has grown nicely.
HAE has a better Operating Margin (15.43%) than 86.10% of its industry peers.
HAE's Operating Margin has improved in the last couple of years.
HAE's Gross Margin has improved in the last couple of years.

Every day, new Affordable Growth stocks can be found on ChartMill in our Affordable Growth screener.

For an up to date full fundamental analysis you can check the fundamental report of HAE

Keep in mind

This article should in no way be interpreted as advice. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.